Mankind Pharma draws buy calls on 57% jump since IPO
The company’s stock has surged 57% since listing, driving its market value to more than $8 billion. It has already drawn nine buy ratings and one hold recommendation. Read More The company’s stock has surged 57% since listing, driving its… Read More »Mankind Pharma draws buy calls on 57% jump since IPO







